收费全文 | 14491篇 |
免费 | 1171篇 |
国内免费 | 41篇 |
耳鼻咽喉 | 425篇 |
儿科学 | 456篇 |
妇产科学 | 401篇 |
基础医学 | 2081篇 |
口腔科学 | 326篇 |
临床医学 | 1304篇 |
内科学 | 3027篇 |
皮肤病学 | 248篇 |
神经病学 | 1705篇 |
特种医学 | 394篇 |
外科学 | 1488篇 |
综合类 | 185篇 |
一般理论 | 19篇 |
预防医学 | 1337篇 |
眼科学 | 241篇 |
药学 | 1042篇 |
中国医学 | 20篇 |
肿瘤学 | 1004篇 |
2023年 | 100篇 |
2022年 | 190篇 |
2021年 | 381篇 |
2020年 | 216篇 |
2019年 | 338篇 |
2018年 | 383篇 |
2017年 | 257篇 |
2016年 | 293篇 |
2015年 | 380篇 |
2014年 | 429篇 |
2013年 | 599篇 |
2012年 | 894篇 |
2011年 | 902篇 |
2010年 | 529篇 |
2009年 | 426篇 |
2008年 | 766篇 |
2007年 | 722篇 |
2006年 | 728篇 |
2005年 | 727篇 |
2004年 | 631篇 |
2003年 | 595篇 |
2002年 | 490篇 |
2001年 | 320篇 |
2000年 | 369篇 |
1999年 | 314篇 |
1998年 | 163篇 |
1997年 | 115篇 |
1996年 | 104篇 |
1995年 | 104篇 |
1994年 | 89篇 |
1993年 | 84篇 |
1992年 | 201篇 |
1991年 | 167篇 |
1990年 | 217篇 |
1989年 | 187篇 |
1988年 | 195篇 |
1987年 | 189篇 |
1986年 | 180篇 |
1985年 | 164篇 |
1984年 | 131篇 |
1983年 | 114篇 |
1982年 | 80篇 |
1981年 | 82篇 |
1980年 | 72篇 |
1979年 | 106篇 |
1978年 | 77篇 |
1977年 | 74篇 |
1975年 | 72篇 |
1973年 | 69篇 |
1972年 | 61篇 |
The common marmoset (Callithrix jacchus) is a useful experimental animal to evaluate the pharmacokinetics of drug candidates. Cytochrome P450 (P450) 2B enzyme in marmoset livers has been identified; however, only limited information on the enzymatic properties and distribution has been available.
Marmoset P450 2B6 amino acids showed high sequence identities (>86%) with those of primates including humans and cynomolgus monkeys. Phylogenetic analysis using amino acid sequences indicated that marmoset P450 2B6 was closer to human and cynomolgus monkey P450 2B6 than to P450 2B orthologs of other species, including pigs, dogs, rabbits and rodents.
Quantitative polymerase chain reaction analysis using specific primers showed P450 2B6 mRNA predominantly expressed in livers among the five marmoset tissues, similar to those of humans and cynomolgus monkeys.
Marmoset P450 2B6 heterologously expressed in Escherichia coli membranes oxidized 7-ethoxycoumarin, pentoxyresorufin, propofol and testosterone, at roughly similar rates to those of humans and/or cynomolgus monkeys. A high capacity of marmoset P450 2B6 with propofol 4-hydroxylation (at low ionic strength conditions) with a low Km value was relatively comparable to that for marmoset livers.
These results collectively indicated a high propofol 4-hydroxylation activity of P450 2B6 expressed in marmoset livers.
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献Methods: [11C]WAY100635, [18F]altanserin and positron emission tomography were used to compare 5-HT1A and 5-HT2A binding in MDD patients divided into eight past suicide attempters (>4yrs prior to scanning) and eight lifetime non-attempters, and both groups were compared to eight healthy volunteers.
Results: The two receptor types differed in binding pattern across brain regions from each other, but there were no differences in binding between healthy volunteers and the two depressed groups or between depressed suicide attempters and non-attempters. No effects of depression severity or lifetime aggression were observed for either receptor.
Conclusion: Limitations of this study include small sample size and absence of high lethality suicide attempts in the depressed attempter group. No trait-like binding correlations with past suicide attempt or current depression were observed. Given the heterogeneity of nonfatal suicidal behavior, a larger sample study emphasizing higher lethality suicide attempts may find the serotonin biological phenotype seen in suicide decedents. 相似文献